Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023-Reference-Cited by-同舟云学术

Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

Published:2024-01-25 Issue:4 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Bolluyt Dita C¹,Euser Sjoerd M²³,Souverein Dennis²³,van Rossum Annemarie MC⁴,Kalpoe Jayant³,van Westreenen Mireille⁵,Goeijenbier Marco⁶⁷,Snijders Dominic⁸,Eggink Dirk⁹,Jongenotter Femke⁹,van Lelyveld Steven FL²¹,van Houten Marlies A²¹⁰

Affiliation:

1. Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands

2. These authors contributed equally to this work and share authorship.

3. Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands

4. Department of Paediatrics, Erasmus MC University Medical Centre, Rotterdam, the Netherlands

5. Department of Medical Microbiology, Erasmus MC University Medical centre, Rotterdam, the Netherlands

6. Department of Intensive Care Medicine, Erasmus MC University Medical Centre, Rotterdam, the Netherlands

7. Department of Intensive Care Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands

8. Department of Pulmonary Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands

9. Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

10. Department of Paediatrics, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands

Abstract

Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference25 articles.

1. Things that could be Mycoplasma pneumoniae.;de Groot;J Infect,2017

2. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection.;Søndergaard;PLoS One,2018

3. Mycoplasma pneumoniae and its role as a human pathogen.;Waites;Clin Microbiol Rev,2004

4. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.;Meyer Sauteur;Euro Surveill,2022

5. Nasal discharge: A unique enhanced alternative for the detection of respiratory pathogens in adults.;Fourie;J Med Virol,2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological characteristics and early predict model of children Mycoplasma Pneumoniae Pneumonia outbreaks after the COVID-19 in Shandong;Scientific Reports;2024-08-27

2. Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China;Frontiers in Cellular and Infection Microbiology;2024-08-16

3. An outbreak of Mycoplasma pneumoniae in children after the COVID-19 pandemic, Shanghai, China, 2023;Frontiers in Microbiology;2024-08-14

4. Persistent elevation in incidence of pneumonia in children in England, 2023/24;Eurosurveillance;2024-08-08

5. Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in Beijing, China in 2023;Frontiers in Microbiology;2024-08-06